Molecullar Rx, Inc.
7Patents
0Active
7Granted
26Portfolio score
Filing activity: Jun 16, 1989 → Oct 28, 1996
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5883227A | Multiple sclerosis associated polypeptide | Emerging Cross-Sectional Technologies | 43 | Expired |
| US4966753A | Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms | Human Necessities | 34 | Expired |
| US5645997A | Assay and treatment for demyelinating diseases such as multiple sclerosis, related hybridomas and monoclonal antibodies | Emerging Cross-Sectional Technologies | 21 | Expired |
| US5846532A | Method and composition for the treatment of disorders involving immunological dysfunction | Chemistry; Metallurgy | 7 | Expired |
| US5558863A | Method for treatment of herpes virus infections | Human Necessities | 3 | Expired |
| US5736133A | Method and composition for the treatment of a individual infected with an immunodeficiency virus | Human Necessities | 3 | Expired |
| US5804188A | Method and composition for treatment of disorders involving immunological dysfunction | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.